rs148585727

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP3BP4_StrongBP6_Very_StrongBS1BS2

The NM_170606.3(KMT2C):​c.10763C>T​(p.Ser3588Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00312 in 1,614,094 control chromosomes in the GnomAD database, including 17 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0028 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0031 ( 13 hom. )

Consequence

KMT2C
NM_170606.3 missense

Scores

9
6
3

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3O:1

Conservation

PhyloP100: 9.59

Publications

17 publications found
Variant links:
Genes affected
KMT2C (HGNC:13726): (lysine methyltransferase 2C) This gene is a member of the myeloid/lymphoid or mixed-lineage leukemia (MLL) family and encodes a nuclear protein with an AT hook DNA-binding domain, a DHHC-type zinc finger, six PHD-type zinc fingers, a SET domain, a post-SET domain and a RING-type zinc finger. This protein is a member of the ASC-2/NCOA6 complex (ASCOM), which possesses histone methylation activity and is involved in transcriptional coactivation. [provided by RefSeq, Jul 2008]
KMT2C Gene-Disease associations (from GenCC):
  • Kleefstra syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Illumina, Ambry Genetics, Broad Center for Mendelian Genomics
  • syndromic intellectual disability
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

PP3
Multiple lines of computational evidence support a deleterious effect 7: AlphaMissense, BayesDel_noAF, Eigen, phyloP100way_vertebrate, PROVEAN, REVEL, REVEL [when max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.014497042).
BP6
Variant 7-152162814-G-A is Benign according to our data. Variant chr7-152162814-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 134789.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00281 (428/152228) while in subpopulation NFE AF = 0.00393 (267/68016). AF 95% confidence interval is 0.00354. There are 4 homozygotes in GnomAd4. There are 228 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 428 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KMT2CNM_170606.3 linkc.10763C>T p.Ser3588Leu missense_variant Exon 43 of 59 ENST00000262189.11 NP_733751.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KMT2CENST00000262189.11 linkc.10763C>T p.Ser3588Leu missense_variant Exon 43 of 59 1 NM_170606.3 ENSP00000262189.6

Frequencies

GnomAD3 genomes
AF:
0.00281
AC:
428
AN:
152110
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000725
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00190
Gnomad ASJ
AF:
0.00490
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.00735
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00393
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00268
AC:
673
AN:
250878
AF XY:
0.00265
show subpopulations
Gnomad AFR exome
AF:
0.00111
Gnomad AMR exome
AF:
0.000896
Gnomad ASJ exome
AF:
0.00308
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00703
Gnomad NFE exome
AF:
0.00352
Gnomad OTH exome
AF:
0.00294
GnomAD4 exome
AF:
0.00315
AC:
4602
AN:
1461866
Hom.:
13
Cov.:
33
AF XY:
0.00316
AC XY:
2297
AN XY:
727232
show subpopulations
African (AFR)
AF:
0.000627
AC:
21
AN:
33480
American (AMR)
AF:
0.000917
AC:
41
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00367
AC:
96
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.000881
AC:
76
AN:
86256
European-Finnish (FIN)
AF:
0.00627
AC:
335
AN:
53410
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5768
European-Non Finnish (NFE)
AF:
0.00348
AC:
3871
AN:
1111996
Other (OTH)
AF:
0.00257
AC:
155
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
271
542
814
1085
1356
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
126
252
378
504
630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00281
AC:
428
AN:
152228
Hom.:
4
Cov.:
32
AF XY:
0.00306
AC XY:
228
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.000722
AC:
30
AN:
41528
American (AMR)
AF:
0.00190
AC:
29
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00490
AC:
17
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.000416
AC:
2
AN:
4812
European-Finnish (FIN)
AF:
0.00735
AC:
78
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00393
AC:
267
AN:
68016
Other (OTH)
AF:
0.00237
AC:
5
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
20
41
61
82
102
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00353
Hom.:
5
Bravo
AF:
0.00228
TwinsUK
AF:
0.00378
AC:
14
ALSPAC
AF:
0.00415
AC:
16
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00384
AC:
33
ExAC
AF:
0.00253
AC:
307
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00371
EpiControl
AF:
0.00273

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Aug 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

KMT2C: BS2

Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

KMT2C-related disorder Benign:1
Dec 28, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

not specified Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.83
BayesDel_addAF
Uncertain
0.11
D
BayesDel_noAF
Pathogenic
0.39
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.18
T;T;.
Eigen
Pathogenic
0.80
Eigen_PC
Pathogenic
0.76
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.0
.;D;D
M_CAP
Uncertain
0.16
D
MetaRNN
Benign
0.014
T;T;T
MetaSVM
Pathogenic
0.89
D
MutationAssessor
Uncertain
2.4
M;M;.
PhyloP100
9.6
PrimateAI
Uncertain
0.70
T
PROVEAN
Uncertain
-3.1
D;D;D
REVEL
Pathogenic
0.71
Sift
Pathogenic
0.0
D;D;D
Sift4G
Pathogenic
0.0
.;.;D
Vest4
0.81
ClinPred
0.036
T
GERP RS
5.5
Varity_R
0.49
gMVP
0.45
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148585727; hg19: chr7-151859899; COSMIC: COSV51415711; COSMIC: COSV51415711; API